Ravulizumab stabilizes life-threating intravascular hemolysis following delayed hemolytic transfusion reaction due to alloantibodies anti-e and anti-Jka: the first successful administration
Ravulizumab 可稳定由抗-e 和抗-Jka 同种抗体引起的迟发性溶血性输血反应后危及生命的血管内溶血：首次成功给药
期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-025-06585-7
Bezirgiannidou, Zoe; Stamatiou, Iliana; Theodoridis, Theodoros M; Kontekaki, Eftychia; Panagiotopoulos, Emmanouil; Misidou, Christina; Vrachiolias, George; Malkots, Bouse; Papoutselis, Menelaos; Kotsianidis, Ioannis; Spanoudakis, Emmanouil; Liapis, Konstantinos
